{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:10:55Z","timestamp":1790867455014,"version":"4.1.0"},"reference-count":65,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004410","name":"T\u00fcrkiye Bilimsel ve Teknolojik Ara\u015ftirma Kurumu","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004006","name":"Bilimsel Ara\u015ftirma Projeleri Birimi, Istanbul \u00dcniversitesi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004006","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunology Letters"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.imlet.2019.10.006","type":"journal-article","created":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T18:57:23Z","timestamp":1570215443000},"page":"63-69","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["CD3-CD56+ NK cells display an inflammatory profile in RR-MS patients"],"prefix":"10.1016","volume":"216","author":[{"given":"Ilhan","family":"Tahrali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umut Can","family":"Kucuksezer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilgun","family":"Akdeniz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayse","family":"Altintas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ugur","family":"Uygunoglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esin","family":"Aktas-Cetin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnur","family":"Deniz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10076","key":"10.1016\/j.imlet.2019.10.006_bib0005","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/S0140-6736(16)30959-X","article-title":"Diagnosis of multiple sclerosis: progress and challenges","volume":"389","author":"Brownlee","year":"2017","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.imlet.2019.10.006_bib0010","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1212\/WNL.0000000000000560","article-title":"Defining the clinical course of multiple sclerosis: the 2013 revisions","volume":"83","author":"Lublin","year":"2014","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.imlet.2019.10.006_bib0015","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1474-4422(11)70274-5","article-title":"Clinically isolated syndromes","volume":"11","author":"Miller","year":"2012","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.imlet.2019.10.006_bib0020","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s11481-013-9467-3","article-title":"The immune pathogenesis of multiple sclerosis","volume":"8","author":"Weissert","year":"2013","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"2","key":"10.1016\/j.imlet.2019.10.006_bib0025","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/cei.12878","article-title":"Circulating immune cells in multiple sclerosis","volume":"187","author":"Jones","year":"2017","journal-title":"Clin. Exp. Immunol."},{"issue":"Suppl 1","key":"10.1016\/j.imlet.2019.10.006_bib0030","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00415-008-1002-8","article-title":"A shift from adaptive to innate immunity: a potential mechanism of disease progression in multiple sclerosis","volume":"255","author":"Weiner","year":"2008","journal-title":"J. Neurol."},{"issue":"3","key":"10.1016\/j.imlet.2019.10.006_bib0035","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.clim.2008.02.001","article-title":"Tumor associated antigen and interleukin-12 mRNA transfected dendritic cells enhance effector function of natural killer cells and antigen specific T-cells","volume":"127","author":"Bontkes","year":"2008","journal-title":"Clin. Immunol."},{"issue":"8","key":"10.1016\/j.imlet.2019.10.006_bib0040","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1158\/1078-0432.CCR-12-1243","article-title":"Growth and activation of natural killer cells ex vivo from children with neuroblastoma for adoptive cell therapy","volume":"19","author":"Liu","year":"2013","journal-title":"Clin. Cancer Res."},{"issue":"5","key":"10.1016\/j.imlet.2019.10.006_bib0045","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0123340","article-title":"Interleukin-15 dendritic cells harness NK cell cytotoxic effector function in a contact- and IL-15-Dependent manner","volume":"10","author":"Anguille","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.imlet.2019.10.006_bib0050","doi-asserted-by":"crossref","first-page":"892","DOI":"10.3389\/fimmu.2017.00892","article-title":"CD56 in the Immune System: More Than a Marker for Cytotoxicity?","volume":"8","author":"Van Acker","year":"2017","journal-title":"Front. Immunol."},{"issue":"18","key":"10.1016\/j.imlet.2019.10.006_bib0055","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1182\/blood-2013-01-476606","article-title":"Soluble ligands for NK cell receptors promote evasion of chronic lymphocytic leukemia cells from NK cell anti-tumor activity","volume":"121","author":"Reiners","year":"2013","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.imlet.2019.10.006_bib0060","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1182\/blood.V76.12.2421.2421","article-title":"Biology and clinical relevance of human natural killer cells","volume":"76","author":"Robertson","year":"1990","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.imlet.2019.10.006_bib0065","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/ni1581","article-title":"Up on the tightrope: natural killer cell activation and inhibition","volume":"9","author":"Lanier","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.imlet.2019.10.006_bib0070","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1146\/annurev-immunol-020711-075005","article-title":"Controlling natural killer cell responses: integration of signals for activation and inhibition","volume":"31","author":"Long","year":"2013","journal-title":"Annu. Rev. Immunol."},{"issue":"4","key":"10.1016\/j.imlet.2019.10.006_bib0075","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.it.2005.02.007","article-title":"Cellular ligands of activating NK receptors","volume":"26","author":"Bottino","year":"2005","journal-title":"Trends Immunol."},{"key":"10.1016\/j.imlet.2019.10.006_bib0080","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1600-065X.2008.00660.x","article-title":"Negative signaling by inhibitory receptors: the NK cell paradigm","volume":"224","author":"Long","year":"2008","journal-title":"Immunol. Rev."},{"issue":"3","key":"10.1016\/j.imlet.2019.10.006_bib0085","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/imm.12921","article-title":"Natural killer cell cytotoxicity and its regulation by inhibitory receptors","volume":"154","author":"Kumar","year":"2018","journal-title":"Immunology"},{"issue":"7230","key":"10.1016\/j.imlet.2019.10.006_bib0090","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/nature07537","article-title":"A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity","volume":"457","author":"Cella","year":"2009","journal-title":"Nature"},{"issue":"15","key":"10.1016\/j.imlet.2019.10.006_bib0095","doi-asserted-by":"crossref","first-page":"7750","DOI":"10.1128\/JVI.00187-10","article-title":"Interleukin-22 (IL-22) production by pulmonary Natural Killer cells and the potential role of IL-22 during primary influenza virus infection","volume":"84","author":"Guo","year":"2010","journal-title":"J. Virol."},{"issue":"2","key":"10.1016\/j.imlet.2019.10.006_bib0100","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.imlet.2013.05.001","article-title":"IL-27 suppresses the production of IL-22 in human CD4(+) T cells by inducing the expression of SOCS1","volume":"152","author":"Wang","year":"2013","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.imlet.2019.10.006_bib0105","doi-asserted-by":"crossref","DOI":"10.1146\/annurev-immunol-032414-112123","article-title":"Interleukin-22: immunobiology and pathology","author":"Dudakov","year":"2015","journal-title":"Annu. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.imlet.2019.10.006_bib0110","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1016\/j.intimp.2015.08.016","article-title":"Exploring the role of interleukin-22 in neurological and autoimmune disorders","volume":"28","author":"Xin","year":"2015","journal-title":"Int. Immunopharmacol."},{"issue":"1\u20132","key":"10.1016\/j.imlet.2019.10.006_bib0115","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.cca.2008.11.009","article-title":"Decreased serum IL-22 levels in patients with systemic lupus erythematosus","volume":"401","author":"Pan","year":"2009","journal-title":"Clin. Chim. Acta"},{"issue":"4","key":"10.1016\/j.imlet.2019.10.006_bib0120","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1136\/ard.2008.097089","article-title":"Decreased plasma IL22 levels, but not increased IL17 and IL23 levels, correlate with disease activity in patients with systemic lupus erythematosus","volume":"68","author":"Cheng","year":"2009","journal-title":"Ann. Rheum. Dis."},{"issue":"7","key":"10.1016\/j.imlet.2019.10.006_bib0125","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.3899\/jrheum.111027","article-title":"Increased serum interleukin 22 in patients with rheumatoid arthritis and correlation with disease activity","volume":"39","author":"da Rocha","year":"2012","journal-title":"J. Rheumatol."},{"issue":"11","key":"10.1016\/j.imlet.2019.10.006_bib0130","doi-asserted-by":"crossref","first-page":"6883","DOI":"10.4049\/jimmunol.1001392","article-title":"IL-22RA2 associates with multiple sclerosis and macrophage effector mechanisms in experimental neuroinflammation","volume":"185","author":"Beyeen","year":"2010","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.imlet.2019.10.006_bib0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0027473","article-title":"Increase in Th17 and T-reg lymphocytes and decrease of IL22 correlate with the recovery phase of acute EAE in rat","volume":"6","author":"Almolda","year":"2011","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.imlet.2019.10.006_bib0140","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1189\/jlb.5A0813-463RR","article-title":"Th22 cells are expanded in multiple sclerosis and are resistant to IFN-beta","volume":"96","author":"Rolla","year":"2014","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.imlet.2019.10.006_bib0145","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.clim.2018.02.005","article-title":"Dysfunction of CD3(-)CD16(+)CD56(dim) and CD3(-)CD16(-)CD56(bright) NK cell subsets in RR-MS patients","volume":"193","author":"Tahrali","year":"2018","journal-title":"Clin. Immunol."},{"issue":"2","key":"10.1016\/j.imlet.2019.10.006_bib0150","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann. Neurol."},{"issue":"3","key":"10.1016\/j.imlet.2019.10.006_bib0155","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.clim.2011.09.006","article-title":"Natural killer cell phenotype and clinical response to interferon-beta therapy in multiple sclerosis","volume":"141","author":"Martinez-Rodriguez","year":"2011","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.imlet.2019.10.006_bib0160","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.3389\/fimmu.2018.01219","article-title":"The role of natural killer group 2, member d in chronic inflammation and autoimmunity","volume":"9","author":"Babic","year":"2018","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.imlet.2019.10.006_bib0165","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1158\/2326-6066.CIR-15-0098","article-title":"NKG2D receptor and its ligands in host defense","volume":"3","author":"Lanier","year":"2015","journal-title":"Cancer Immunol. Res."},{"issue":"16","key":"10.1016\/j.imlet.2019.10.006_bib0170","doi-asserted-by":"crossref","first-page":"9452","DOI":"10.1073\/pnas.1632807100","article-title":"Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis","volume":"100","author":"Groh","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"7","key":"10.1016\/j.imlet.2019.10.006_bib0175","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1053\/j.gastro.2007.03.025","article-title":"CD4+NKG2D+ T cells in Crohn\u2019s disease mediate inflammatory and cytotoxic responses through MICA interactions","volume":"132","author":"Allez","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.imlet.2019.10.006_bib0180","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1146\/annurev-immunol-032712-095951","article-title":"Regulation of ligands for the NKG2D activating receptor","volume":"31","author":"Raulet","year":"2013","journal-title":"Annu. Rev. Immunol."},{"issue":"4\u20135","key":"10.1016\/j.imlet.2019.10.006_bib0185","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.humimm.2008.01.021","article-title":"Soluble MHC class I chain-related protein B serum levels correlate with disease activity in relapsing-remitting multiple sclerosis","volume":"69","author":"Fernandez-Morera","year":"2008","journal-title":"Hum. Immunol."},{"issue":"1","key":"10.1016\/j.imlet.2019.10.006_bib0190","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1399-0039.2008.01066.x","article-title":"Genetic influence of the nonclassical major histocompatibility complex class I molecule MICB in multiple sclerosis susceptibility","volume":"72","author":"Fernandez-Morera","year":"2008","journal-title":"Tissue Antigens"},{"issue":"11","key":"10.1016\/j.imlet.2019.10.006_bib0195","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0081455","article-title":"CD4+NKG2D+ T cells exhibit enhanced migratory and encephalitogenic properties in neuroinflammation","volume":"8","author":"Ruck","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.imlet.2019.10.006_bib0200","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1182\/blood-2006-10-052720","article-title":"Antigen-activated human T lymphocytes express cell-surface NKG2D ligands via an ATM\/ATR-dependent mechanism and become susceptible to autologous NK- cell lysis","volume":"110","author":"Cerboni","year":"2007","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.imlet.2019.10.006_bib0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031959","article-title":"Cytotoxicity of CD56(bright) NK cells towards autologous activated CD4+ T cells is mediated through NKG2D, LFA-1 and TRAIL and dampened via CD94\/NKG2A","volume":"7","author":"Nielsen","year":"2012","journal-title":"PLoS One"},{"issue":"5","key":"10.1016\/j.imlet.2019.10.006_bib0210","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1523\/JNEUROSCI.4402-06.2007","article-title":"NKG2D-mediated cytotoxicity toward oligodendrocytes suggests a mechanism for tissue injury in multiple sclerosis","volume":"27","author":"Saikali","year":"2007","journal-title":"J. Neurosci."},{"issue":"6908","key":"10.1016\/j.imlet.2019.10.006_bib0215","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/nature01112","article-title":"Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation","volume":"419","author":"Groh","year":"2002","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.imlet.2019.10.006_bib0220","doi-asserted-by":"crossref","first-page":"720","DOI":"10.4049\/jimmunol.175.2.720","article-title":"Systemic NKG2D down-regulation impairs NK and CD8 T cell responses in vivo","volume":"175","author":"Wiemann","year":"2005","journal-title":"J. Immunol."},{"issue":"11","key":"10.1016\/j.imlet.2019.10.006_bib0225","doi-asserted-by":"crossref","first-page":"7249","DOI":"10.4049\/jimmunol.180.11.7249","article-title":"Human tumor-derived exosomes down-modulate NKG2D expression","volume":"180","author":"Clayton","year":"2008","journal-title":"J. Immunol."},{"issue":"8","key":"10.1016\/j.imlet.2019.10.006_bib0230","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18081677","article-title":"Regulation of NKG2D-Dependent NK cell functions: the yin and the yang of receptor endocytosis","volume":"18","author":"Molfetta","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.imlet.2019.10.006_bib0235","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.cytogfr.2018.08.001","article-title":"Natural killer cells in inflammation and autoimmunity","volume":"42","author":"Zitti","year":"2018","journal-title":"Cytokine Growth Factor Rev."},{"issue":"3","key":"10.1016\/j.imlet.2019.10.006_bib0240","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.immuni.2015.02.008","article-title":"Cytomegalovirus infection drives adaptive epigenetic diversification of NK cells with altered signaling and effector function","volume":"42","author":"Schlums","year":"2015","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.imlet.2019.10.006_bib0245","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1084\/jem.20011149","article-title":"Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells","volume":"195","author":"Ferlazzo","year":"2002","journal-title":"J. Exp. Med."},{"issue":"1","key":"10.1016\/j.imlet.2019.10.006_bib0250","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12985-017-0719-3","article-title":"Multiple sclerosis: an example of pathogenic viral interaction?","volume":"14","author":"Fierz","year":"2017","journal-title":"Virol. J."},{"issue":"3","key":"10.1016\/j.imlet.2019.10.006_bib0255","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.jaci.2016.11.045","article-title":"Recognition of viral and self-antigens by TH1 and TH1\/TH17 central memory cells in patients with multiple sclerosis reveals distinct roles in immune surveillance and relapses","volume":"140","author":"Paroni","year":"2017","journal-title":"J. Allergy Clin. Immunol."},{"issue":"5","key":"10.1016\/j.imlet.2019.10.006_bib0260","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1084\/jem.189.5.787","article-title":"NKp44, a triggering receptor involved in tumor cell lysis by activated human natural killer cells, is a novel member of the immunoglobulin superfamily","volume":"189","author":"Cantoni","year":"1999","journal-title":"J. Exp. Med."},{"issue":"11","key":"10.1016\/j.imlet.2019.10.006_bib0265","doi-asserted-by":"crossref","first-page":"5693","DOI":"10.4049\/jimmunol.1102267","article-title":"Proliferating cell nuclear antigen is a novel inhibitory ligand for the natural cytotoxicity receptor NKp44","volume":"187","author":"Rosental","year":"2011","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.imlet.2019.10.006_bib0270","doi-asserted-by":"crossref","first-page":"5199","DOI":"10.1073\/pnas.95.9.5199","article-title":"HLA-E is a major ligand for the natural killer inhibitory receptor CD94\/NKG2A","volume":"95","author":"Lee","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"4","key":"10.1016\/j.imlet.2019.10.006_bib0275","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/imm.12012","article-title":"Increased HLA-E expression in white matter lesions in multiple sclerosis","volume":"137","author":"Durrenberger","year":"2012","journal-title":"Immunology"},{"issue":"6","key":"10.1016\/j.imlet.2019.10.006_bib0280","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1073\/pnas.0914732107","article-title":"Analysis of the cellular mechanism underlying inhibition of EAE after treatment with anti-NKG2A F(ab\u2019)2","volume":"107","author":"Leavenworth","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.imlet.2019.10.006_bib0285","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.immuni.2007.03.017","article-title":"Regulation of activated CD4+ T cells by NK cells via the Qa-1-NKG2A inhibitory pathway","volume":"26","author":"Lu","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.imlet.2019.10.006_bib0290","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jaut.2016.04.003","article-title":"Dysregulation of regulatory CD56(bright) NK cells\/T cells interactions in multiple sclerosis","volume":"72","author":"Laroni","year":"2016","journal-title":"J. Autoimmun."},{"issue":"1","key":"10.1016\/j.imlet.2019.10.006_bib0295","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cytogfr.2012.07.002","article-title":"Emerging role of interleukin-22 in autoimmune diseases","volume":"24","author":"Pan","year":"2013","journal-title":"Cytokine Growth Factor Rev."},{"issue":"2","key":"10.1016\/j.imlet.2019.10.006_bib0300","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.immuni.2004.07.007","article-title":"IL-22 increases the innate immunity of tissues","volume":"21","author":"Wolk","year":"2004","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.imlet.2019.10.006_bib0305","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/nm1710","article-title":"IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia","volume":"14","author":"Aujla","year":"2008","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.imlet.2019.10.006_bib0310","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.cytogfr.2010.08.002","article-title":"Interleukin-22: a cytokine produced by T, NK and NKT cell subsets, with importance in the innate immune defense and tissue protection","volume":"21","author":"Witte","year":"2010","journal-title":"Cytokine Growth Factor Rev."},{"issue":"10","key":"10.1016\/j.imlet.2019.10.006_bib0315","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/nm1651","article-title":"Human TH17 lymphocytes promote blood-brain barrier disruption and central nervous system inflammation","volume":"13","author":"Kebir","year":"2007","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.imlet.2019.10.006_bib0320","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/bph.12196","article-title":"IL-22 in tissue-protective therapy","volume":"169","author":"Muhl","year":"2013","journal-title":"Br. J. Pharmacol."},{"issue":"7","key":"10.1016\/j.imlet.2019.10.006_bib0325","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/gene.2014.36","article-title":"The multiple sclerosis risk gene IL22RA2 contributes to a more severe murine autoimmune neuroinflammation","volume":"15","author":"Laaksonen","year":"2014","journal-title":"Genes Immun."}],"container-title":["Immunology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247819303384?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165247819303384?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T07:36:06Z","timestamp":1759044966000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165247819303384"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":65,"alternative-id":["S0165247819303384"],"URL":"https:\/\/doi.org\/10.1016\/j.imlet.2019.10.006","relation":{},"ISSN":["0165-2478"],"issn-type":[{"value":"0165-2478","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CD3-CD56+ NK cells display an inflammatory profile in RR-MS patients","name":"articletitle","label":"Article Title"},{"value":"Immunology Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imlet.2019.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 European Federation of Immunological Societies. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}